How vaccine protection changes over time and what the evidence shows about booster doses
Immunity from vaccination isn't always permanent. For some vaccines, protection lasts a lifetime. For others, it fades over months or years, requiring booster doses to maintain adequate protection.
Understanding waning immunity is essential for public health planning and personal health decisions. It's also a source of confusion — headlines about "waning immunity" can sound alarming, even when protection against severe disease remains strong.
This page explains the science behind immunity waning, which vaccines require boosters, and what the evidence actually shows about declining protection.
Antibodies in the blood gradually decline after vaccination or infection. This is measured by antibody titers (concentrations). After months or years, antibody levels may fall below the threshold needed to prevent infection entirely.
Memory B cells and T cells can persist for decades, providing longer-term protection. These cells can rapidly produce antibodies and mount cellular responses upon re-exposure to the pathogen.
Key distinction: waning antibody levels do not necessarily mean loss of protection against severe disease. Memory cells can mount a rapid response even if antibodies have declined, often preventing hospitalization and death even if mild infection occurs.
Note: Duration data comes from post-licensure surveillance and ongoing studies. Estimates may be updated as more data becomes available.
A critical distinction that is frequently lost in media coverage:
Vaccine-induced protection against mild or symptomatic infection typically declines faster than protection against severe disease. This is because preventing infection entirely requires high circulating antibody levels, while preventing severe disease relies more on memory cell responses.
Protection against hospitalization, ICU admission, and death tends to persist longer than protection against any infection. Memory B and T cells can mount rapid responses that limit disease severity even when antibody levels have declined.
Booster recommendations are made by ACIP (Advisory Committee on Immunization Practices) based on evidence of waning immunity combined with continued risk of exposure. Factors considered include:
Not all vaccines require boosters. The recommendation depends on the specific vaccine, pathogen, and population risk profile.
Amanna IJ, Slifka MK. "Mechanisms that determine plasma cell lifespan and the duration of humoral immunity." Immunological Reviews. 2010;236(1):125-138. https://doi.org/10.1111/j.1600-065X.2010.00912.x
Crotty S. "Hybrid immunity." Science. 2021;372(6549):1392-1393. https://doi.org/10.1126/science.abj2258
CDC. "Stay Up to Date with COVID-19 Vaccines." Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html
Patel MM, et al. "Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19." New England Journal of Medicine. 2022;386:1615-1616. https://doi.org/10.1056/NEJMc2200933
WHO. "Immunological Basis for Immunization Series." World Health Organization. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/who-immunological-basis-for-immunization-series